In his fifth decade as physician, healthcare executive, educator and infectious disease/cancer researcher, Dr. Stephen Schimpff is one of the world's foremost experts on healthcare. He is the former Chief Executive Officer of the University of Maryland Medical Center, which includes the world's preeminent trauma center, an NCI certified cancer center, and one of the country's largest kidney transplant programs. The Medical Center admits nearly 40,000 patients per year, mostly for complex tertiary care, and employs more than 5,000 people with a budget of over $1 billion. Dr. Schimpff also is a professor of medicine at the University of Maryland School of Medicine where he teaches residents and fellows in oncology and infectious diseases and is a former professor of public policy at the University of Maryland, College Park.
From the bedside -- where he treated patients with acute leukemia and lymphoma, to the boardroom -- where he served as the CEO of a major academic medical center, Dr. Schimpff has witnessed firsthand the explosion of diagnostic and treatment technologies, including the emergence of the genomics revolution. He also has dealt with the frustrations of trying to manage a large-healthcare organization in an ever-changing healthcare landscape and watched with anguish the development of the primary care shortage and crisis.
He appears frequently on national media as an expert on healthcare and has a gift for explaining the complexities of healthcare delivery and the science of medicine in layman's terms. His passion for advancing healthcare for future generations is embodied in his four books on the topic for the general public, including the newly published "Fixing The Primary Care Crisis - Reclaiming the Patient-Doctor Relationship and Returning Healthcare Decisions to You and Your Doctor."
In addition to his work in educating the public about how changes in the healthcare landscape will affect them, Dr. Schimpff is internationally recognized for his infectious disease/cancer research at the University of Maryland and the National Cancer Institute. His research focused on the causes, prevention, and treatment of infection in cancer patients undergoing aggressive therapy. He has published more than 200 scientific articles on cancer, infectious diseases and healthcare and is board certified in internal medicine, infectious diseases, and medical oncology.
Dr. Schimpff is a senior adviser to Sage Growth Partners and also has been a board member of companies seeking to advance medical devices and technologies and was the lead consultant to the US Army's Telemedicine and Technology Research Center (TATRC) on patient safety and the "OR of the Future." He also conducted a major study of "The Hospital of the Future" for TATRC and was asked to participate in a congressionally-mandated review of the construction of the new Walter Reed National Military Medical Center.
An Eagle Scout, Dr. Schimpff is a 1963 graduate of Rutgers University where he was a Henry Rutgers Scholar. He obtained his M.D. degree in 1967 at Yale Medical School, where he was inducted into Alpha Omega Alpha national honor medical society.
Dr. Schimpff has been married to Carol Rawstrom Schimpff, a retired architect and pension fund asset adviser, for over 50 years. They reside in Maryland and have a cabin in Canaan Valley, West Virginia where they live their passion for the outdoors. They have a daughter, son-in-law, and two wonderful grandsons living in Los Angles.